DMK Pharmaceuticals Corporation (DMKPQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Oct 29, 2025, 4:00 PM EDT
DMK Pharmaceuticals Revenue
DMK Pharmaceuticals had revenue of $9.06K in the quarter ending September 30, 2023, a decrease of -99.40%. This brings the company's revenue in the last twelve months to $3.62M, up 150.33% year-over-year. In the year 2022, DMK Pharmaceuticals had annual revenue of $4.76M with 115.34% growth.
Revenue (ttm)
3.62M
Revenue Growth
+150.33%
P/S Ratio
n/a
Revenue / Employee
301.64K
Employees
12
Market Cap
10.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 4.76M | 2.55M | 115.34% |
| Dec 31, 2021 | 2.21M | -567.91K | -20.45% |
| Dec 31, 2020 | 2.78M | -19.34M | -87.44% |
| Dec 31, 2019 | 22.11M | 7.03M | 46.58% |
| Dec 31, 2018 | 15.09M | 2.01M | 15.40% |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |